The global bioanalytical testing services market was worth USD 2.7 billion in 2020 and is further projected to reach USD 6.1 billion by 2027, at a CAGR of 12.1% during the forecast period (2021-2027).

RAG-17 therapy slowed functional decline and stabilized or improved breathing in people with ALS who carry mutations in the SOD1 gene.

Researchers at the University of Manchester examined patients with asthma taking their medication in a different way. | ITV News Granada ...

Pain-related conditions cost the U.S. economy a staggering $635 billion annually in medical expenses and lost productivity.

Asthma study shows the importance of using the inhaler in line with the body's natural circadian rhythm so that breathing function is improved during sleep ...

Some took a daily inhaler dose between 8 a.m. and 9 a.m.; others a daily dose between 3 p.m. and 4 p.m.; and the rest took two doses — one between 8 a.m. and 9 a.m. and the second between 8 p.m. and 9 ...

SUNRISE-PD evaluating the Company’s anti-inflammatory, insulin-sensitizing candidate bezisterim in patients with Parkinson’s disease who have not ...

A mid-afternoon puff of a preventer inhaler could be the best way for a person with asthma to keep their symptoms under ...

They each had a two-week “washout” period between each dosing regime. While the research team found all regimes appeared to ...